Project Grant HT94252510721
Award Date 8/15/25
Completion Date 8/14/27
Dollars Obligated $673K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $569,851 to the University of Pittsburgh to conduct research on the effectiveness of a traumatic brain injury whole blood test for improving assessment and triage of patients with mild traumatic brain injury in civilian emergency departments. The 4-year project, running from July 1, 2025 to June 30, 2029, aims to generate critical insights on how this novel...
- This Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), provides $2,454,969.00 in funding to the University of Pittsburgh to conduct research on "Biomechanical and Physiological Resilience and Recovery in Load Carriage." The research aims to transform healthcare for military service members and the broader public by advancing biomedical knowledge and developing innovative medical solutions. The award period...
- This $1,526,245 Project Grant awarded on July 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund the "MITOCHONDRIAL INFLAMMATION SYNAPTIC SYSTEMS IMAGING OF NEUROINJURY (MISSION) FOR MILD REPETITIVE TRAUMATIC BRAIN INJURY" research project at the University of Pittsburgh. The project aims to investigate mechanisms and treatments for mild, repetitive traumatic brain injury through research on mitochondrial...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,699,157.00 to the University of Pittsburgh to evaluate the effectiveness of a traumatic brain injury whole blood test in improving assessment and triage for patients with mild traumatic brain injury presenting to civilian emergency departments. The project aims to generate data to support the clinical application of this diagnostic test, which...
- The University of Pittsburgh was awarded a $1,306,281 Project Grant under the Department of the Army's Military Medical Research and Development program (CFDA 12.420) to conduct the "MITOCHONDRIAL INFLAMMATORY SYNAPTIC SYSTEMS IMAGING OF NEUROINJURY (MISSION) FOR MILD REPETITIVE TRAUMATIC BRAIN INJURY" research project. The award began on July 1, 2024 and is scheduled for completion on June 30, 2028. The project aims to study the mechanisms of mitochondrial inflammation and synaptic...
- The University of Pittsburgh was awarded a $2,806,431.00 Project Grant on July 1, 2023 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to optimize small molecule therapeutics to treat focal segmental glomerulosclerosis. This basic, applied, and advanced biomedical research aims to transform health care by developing innovative and impactful medical solutions for Service Members and the American public. The University of Pittsburgh will...
- The University of Pittsburgh received a $454,142.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "FERROPTOSIS AS A METABOLIC VULNERABILITY OF CYCLIN E-HIGH OVARIAN CANCER". This 2-year research project, with a performance period from May 2024 to May 2026, aims to investigate metabolic vulnerabilities in a specific type of ovarian cancer. The University of Pittsburgh is the primary...
- The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The University of Pittsburgh has been awarded a $602,986 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award, effective August 1, 2024 through August 31, 2026, will fund a research project titled "A T CELL-GUIDED APPROACH TO DEVELOP ANTIGEN-SPECIFIC IMMUNOTHERAPIES FOR PEDIATRIC BRAIN TUMORS." This project aims to develop innovative immunotherapies for treating pediatric brain tumors by leveraging the...
- This federal Project Grant award of $4,902,315.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a research project titled "UNDERSTANDING THE EFFECTS OF INTRACAVITARY CONDITIONING IN BREAST CANCER METASTATIC TO THE PLEURA OR THE PERITONEUM" at the University of Pittsburgh. The project aims to conduct advanced biomedical research focused on developing innovative medical solutions to address critical health challenges relevant to...